- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Senores Pharmaceuticals has released its share capital audit report for the quarter recently concluded. The report confirms the company's capital structure, including an Authorised Capital of ₹59 Cr and an Issued Equity Share Capital of 4,60,53,588 shares. All listed shares are held in dematerialized form (57.21% in NSDL and 42.79% in CDSL), with zero physical shares. The report also confirms that the Register of Members is updated and there are no pending dematerialization requests, assuring investors of robust share management and transparency in shareholding data.